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                                   Abstract 
 
 
This study was carried out at Al Shaab Teaching Hospital during the period 
between October 2003- June 2004. 
The objective of this study is to determine the clinical presentation, risk 
factors and the immediate complication of acute myocardical infarction 
among Sudanese females. 
In the final analysis it was found that most of the patient's age range between 
50-70 years. The risk factors were the following: Diabetes mellitus (46%), 
systemic hypertension (40%), positive family history of IHD (23%) and lastly 
smoking (9%). 
Anterior MI was the commonest type (55%) then comes inferior MI (38%) 
followed by posterior MI (7%). 
In addition, it was found that more than half of the patients had elevated 
cardiac enzymes (CK-MB). 
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  ﻤﻠﺨﺹ ﺍﻻﻁﺭﻭﺤﺔ                        
  
  
ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺍﻟﻭﺼﻔﻴﺔ ﺍﺠﺭﻴﺕ ﺒﻤﺴﺘﺸﻔﻰ ﺍﻟﺸﻌﺏ ﺍﻟﺘﻌﻠﻴﻤﻰ ﺨﻼل ﺍﻟﻔﺘﺭﺓ ﻤـﺎ ﺒـﻴﻥ ﺍﻜﺘـﻭﺒﺭ 
 ﻭﻟﻘﺩ ﺨﺼﺼﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻟﻤﻌﺭﻓﺔ ﺍﻟﻌﻭﺍﻤـل ﺍﻟﻤـﺴﺒﺒﺔ ﻟﻠﺫﺒﺤـﺔ 4002 ﻴﻭﻨﻴﻭ ﺍﻟﻰ 3002
  .ﺍﻟﻘﻠﺒﻴﺔ ﻟﺩﻯ ﺍﻟﻤﺭﺍﺓ ﺍﻟﺴﻭﺩﺍﻨﻴﺔ
  . ﺴﻨﺔ07-04ﺸﻤﻠﺕ ﺍﻟﺩﺭﺍﺴﺔ ﻤﺎﺌﺔ ﺍﻤﺭﺍﺓ ﺘﺘﺭﺍﻭﺡ ﺍﻋﻤﺎﺭﻫﻥ ﻤﺎ ﺒﻴﻥ 
ﺒﻴﻨﻤﺎ ﺍﺭﺘﻔﻠﻊ ﻀﻐﻁ ﺍﻟﺩﻡ ﻴـﺸﻜل , %64ﻭﻟﻘﺩ ﺘﺒﻴﻥ ﺍﻥ ﻤﺭﺽ ﺍﻟﺴﻜﺭﻯ ﻋﺎﻤل ﺭﺌﻴﺴﻰ ﺒﻨﺴﺒﺔ 
  %.9ﻭﺍﺨﻴﺭﺍ ﺍﻟﺘﺩﺨﻴﻥ ﺒﻨﺴﺒﺔ % 31ﺜﻡ ﺍﻟﺘﺎﺭﻴﺦ ﺍﻻﺴﺭﻯ ﻨﺴﺒﺔ , %04ﻨﺴﺒﺔ 
ﻓﻰ ﺍﻟﺠﺯﺀ ﺍﻻﻤﺎﻤﻰ ﻤـﻥ ﻋـﻀﻠﺔ ﻤﻥ ﺍﻟﺤﺎﻻﺕ ﻜﺎﻨﺕ ﺍﻟﺫﺒﺤﺔ % 55ﻭ ﻤﻥ ﺍﻟﺠﺩﻴﺭ ﺒﺎﻟﺫﻜﺭ ﺍﻨﻪ 
  .     ﺍﻟﺨﻠﻔﻰﻓﻰ ﺍﻟﺠﺯﺀ % 7ﺍﻟﺠﺯﺀ ﺍﻟﺴﻔﻠﻰ ﻭ ﻓﻰ % 83ﺍﻟﻘﻠﺏ ﺒﻴﻨﻤﺎ 
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     ACUTE MYOCARDIAL INFARCTION 
 DEFINITIONS: 
         Acute myocardial infarction (MI) is a focus of necrosis resulting 
from an in adequate tissue perfusion, it is accompanied by consequent 
hypoxia, accumulation of deleterious metabolites, and signs and 
symptoms of myocardial cell death. Anoxia without decreased perfusion 
can cause M.I but does so only rarely.  
           MI refers also to the typical clinical syndrome that results from 
such ischaemia and that is manifested by signs and symptoms such as 
crushing chest pain, diaphoresis, malignant ventricular arrhythmia, heart 
failure, and shock. However, MI can also present as sudden cardiac death, 
or a typically clinically silent or subtle, also with new onset or accelerated 
angina, Atypical chest pain mimicking (indigestion), impaired cerebral 
perfusion with syncope, and signs simulating those of a cerebrovascular 
accident or altered mental states.  
        Coronary thrombosis is recognized as a potential cause as early as 
1910, and was established unequivocally as the pathophysiologic cause 
by early angiographic study of afflicted patients. (1) 
 
PATHOPHYSIOLOGY: 
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        The most common cause of AMI is narrowing of the epicardial 
blood vessels due to atheromatous plaques rupture with subsequent 
exposure of the basement membrane results in platelet aggregation, 
thrombus formation, fibrin accumulation, haemorrhage in to the plaque, 
in addition to varying degrees of vasospasm. This can result in partial or 
complete occlusion of the vessel for more than 4-6 hours and results in 
irreversible myocardial necrosis, but reperfusion within this period can 
salvage the myocardium and reduce morbidity and mortality. (2) 
 
FREQUENCY: 
         In the US, AMI is a leading cause of morbidity and mortality. 
Approximately 1.3 million cases of nonfatal AMI are reported each year, 
for an annual incidence of approximately 600 per 100,000 people. 
 
 
MORTALITY/MORBIDITY: 
• Approximately 500,000-700,000 deaths caused by ischemic heart 
disease occur in the United States alone. 
• More than one half of deaths occur in the pre hospital setting. 
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• In-hospital, fatalities account for about 5-15% of all deaths. An 
additional 10% of deaths occur in the first year post infarct. 
RISK FACTORS: 
• Gender 
     Male predilection exists in persons aged 40-70 yeas. 
     In persons older than 70 years, no sex predilection exists. 
• AGE: 
     AMI occurs most frequently in persons older than 45 years. 
     Certain subpopulations younger than 45 years are at risk, particularly:    
cocaine users, insulin dependent diabetics, patients with 
hypercholesterolemia, and those with a positive family history of early 
coronary disease. A positive family history includes any first-degree male 
relative aged 45 years or younger or any first-degree female relative aged 
55 years or younger who experienced a myocardial infarction. 
      In younger patients, the diagnosis may be hampered if the physician 
does not maintain a high index of suspicion. 
 HISTORY: 
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? Chest pain, usually pressuring, or squeezing. 
? Pain may radiate to the jaw, neck, arms, back, and epigastrium. 
The left arm is affected more frequently than the right arm. 
? Dyspnoea, which may accompany chest pain or occur as an 
isolated complaint, indicates poor ventricular compliance in the 
setting of acute ischemia 
? Nausea and/or abdominal pain often are present in infarcts 
involving the inferior wall. 
? Anxiety. 
? Light headedness and syncope. 
? Cough. 
? Nausea and vomiting. 
? Diaphoresis. 
? Wheezing. 
? Elderly patients and those with diabetes may have particularly 
subtle presentations and may complain of fatigue, syncope, or 
weakness. 
 
PHYSICAL EXAMINATION: 
? Frequently, physical examination findings are normal. 
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? Patients with ongoing symptoms usually will lie quietly in bed, appear 
pale and diaphoretic. 
? Hypertension may precipitate AMI, or it may reflect elevated 
catecholamines due to anxiety, pain, and exogenous 
sympathomimetics. 
? Hypotension indicates ventricular dysfunction due to ischemia, it 
usually indicates a large infarct and may be observed with a right 
ventricular infarct.  
? Acute valvular dysfunction may be present ; 
? This dysfunction usually involves the papillary muscle. 
? Mitral regurgitation due to papillary muscle ischemia or necrosis may 
be present. 
? Congestive heart failure {CHF} may occur; 
? Neck vein distension. 
? Third heart sound. 
? Rales on pulmonary examination. 
? New or worsening mitral regurgitant murmur may be noted. 
? A fourth heart sound is a common finding in patients with poor 
ventricular compliance that is due to a pre-existing heart disease or 
hypertension. 
? Dysrhythmias may be present; 
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With heart block and right ventricular failure, cannon jugular venous a 
waves may be noted. 
CAUESE of MI: 
? The predominant cause is a rupture of an atherosclerotic plaque with 
subsequent spasm and clot formation. 
? Ventricular hypertrophy e.g. (left ventricular hypertrophy [LVH], 
idiopathic hypertrophic subaortic stenosis [IHSS], and an underlying 
valve disease). 
? Hypoxia due to carbon monoxide poisoning or acute pulmonary 
disorders {infarcts in this setting usually occur when myocardial 
demands are dramatically increased relative to blood supply}. 
? Emboli to coronary arteries, which may be due to cholesterol or 
infectious causes. 
? Coronary artery vasospasm. 
? Arteritis. 
? Coronary anomalies, including aneurysms of the coronary arteries. 
? Cocaine, amphetamines, and ephedrine. 
? Increase after load or inotropic effects, which increase myocardial 
demand. 
? Primary vasospasm of the coronary artery. 
? Risk factors for atherosclerotic plaque formation can be divided in to : 
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• FIXED:            
          Age. 
          Being a male and younger than 70 years. 
          Family history. 
• ALTERABLE: 
     Smoking (Cigerate, Pipe. Shisha) 
     Poorly controlled hypertension. 
     Hyperlipidaemia. 
     Diabetes mellitus. 
     Type A personality. 
     Sedentary lifestyle. 
     Central obesity. 
Laboratory Studies: 
*Creatine kinase –MB (CK-MB) 
  - This is the criterion standard for detection of myocardial necrosis. 
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  - Levels begin to rise within 4 hours after injury, peak at 18-24 hours,   
and subside in days. 
  - Upper limit of reference range values for CK-MB is 3-6% of total CK. 
  - Serial sampling over periods of (6-9) hours will increase the sensitivity 
to nearly 90%. 
  - Over 24 hours, the sensitivity is nearly 100 %. (2)                                              
EFFECT OF MI ON ORGANS OTHER THAN THE 
HEART: 
       Augmentation of pulmonary venous pressure may cause diminished 
pulmonary compliance, dyspnoea,pulmonary vascular redistribution 
{detectable radiographically}, interstitial or alveolar pulmonary odema, 
respiratory decompensation and hypoxemia. Cerebral hypoperfusion may 
result in restlessness, or rarely psychosis coupled with dyspnoea in the 
elderly, it may be manifested only as confusion and combativeness. 
        Increased sympathoadrenal tone reflected by markedly elevated 
plasma catecholamines levels and adrenocortical stimulation may be 
prominent as well.  
       Plasma concentration of atrial natriuretic peptide decreases initially 
but then it increase,perhaps because of heart failure and atrial stretch.   
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       Elevated plasma concentrations of vasopressin ,angiotensin{with B 
adrenergic stimulation of rennin release},and aldosterone contribute to 
fluid retension  and hyponatremia.  
       Impaired pancreatic blood flow inhibits insulin secretion.  
       In addition to the typical increase in erythrocyte sedimentation rate 
and leukocytosis, modestly increased levels of plasma fibrinogen and 
augmented circulating plasminogen activator inhibitor type 1{PAI}-1 
occur as part of the acute phase reaction to MI. Impaired fibrinolysis and 
augmented platelet activation by circulating catecholamines may 
predispose to continuing coronary and ventricular mural thrombosis. 
Plasma viscosity increase is due to increase in fibrinogen, alpha 2 
globulins, and haemo-concentration, several days after the onset of MI, 
most markedly when left ventricular failure or shock supervenes. 
 
FEMALES AND HEART DISEASE: 
          In females coronary heart disease (CHD) is responsible for one in 
every five deaths in the states in 1997. Long thought of as primarily 
affecting men, but we now know that CHD also affect a substantial 
number of women. More women US die from heart disease than any 
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other cause. Experts estimate that 1 in 2 women will die of heart diseases 
or stroke compared with 1 in 25 women who will die of breast cancer.      
          Current statistics reveals significant differences between males and 
females in survival following a myocardial infarction, for example 42% 
of females who have myocardial infarction die within 1 year compared 
with 24% of males. The reasons for this are not well understood. The 
explanation accepted by many is that women tend to develop heart 
disease later in life than do men who are likely to have coexisting chronic 
conditions. However research also has shown that women may not be 
diagnosed or treated as aggressively as men, and their symptoms may be 
very different from those of men who are having a heart attack. In 
addition new studies indicate that men and women react to drugs 
prescribed for heart disease and other conditions quite different; drugs 
that may help men can have serious side effects in women.(3) 
 
RISK OF MI: 
        The aetiology of coronary artery disease (CAD) is multifactor; a 
number of risk factors are known to predispose to the condition, some of 
which cannot be changed such as: Age, Gender, Race, and Family 
history. Whereas other major risk factors such as: serum cholesterol, 
 11
smoking, central obesity, diabetes, and hypertension can be modifiable. 
However not all patients with MI are identified by these risk factors. (4)  
 
Risk Factor of myocardial infarction in females: 
A / Age: 
         Acute myocardial infarction occurs most frequently in persons older 
than 45 years. 
          Certain sub-population younger than 45 years are at risk, such as 
those with hypercholesterolemia or with positive family history for early 
coronary diseases. 
           Positive family history include any 1st degree male relative aged 
45 years or younger, also any 1st degree female relative aged 55 years or 
younger who experienced myocardial infarction. (1) 
          Males have higher incidence of coronary artery diseases than 
premenopausal females. However after the menopause, the incidence of 
atherosclerosis in females approaches that in males. The reason for this 
gender difference are not clearly understood but probably related to the 
loss of the protective effect of oestrogen. 
Females have more favorable risk profile in some respect: 
    -higher HDL cholestrol level. 
    -lower triglyceride level. 
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    -less upper body obesity than males. 
But females also have less favorable risk profile in other respects: 
    -Obesity. 
    -Higher blood pressure. 
    -Higher plasma cholestrol levels. 
    -Higher fibrinogen levels. 
    -Higher incidence for diabetes. 
          The explanation for gender differentiation in IHD is the 
‘cardioprotective’ effect of oestrogen which could be due to suitable lipid    
profile, direct vasodilatation effect or perhaps other factors. 
         HDL cholestrol levels appear to be particularly important risk factor 
in females, it is higher in all age groups of  females especially 
premenopausal and estrogen-treated postmenopausal females. 
        Smoking is another important factor in females.    
        The incidence of IHD increases markedly at menopuase, consistent 
with the hypothesis that estrogens are cardioprotective. A number of 
observational studies have supported this hypothesis by demonstrating 
significant decreases in IHD in females on hormone replacement therapy 
(HRT) either estrogen only or in combination with progestron. However 
the HERS resent clinical trial of HRT for the secondary prevention of 
IHD, showed no significant difference in cardiovascular events between 
therapy with combined continuous conjugated eguine estrogen and that 
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with medroxy progesterone acetate , compared to placebo over four years. 
Indeed, in the HRT group there was about 50% increase in cardiovascular 
events in 1st year of trial. 
         The females Health Initiative is investigating directly the impact of 
various HRT modalities as a primary prevention of IHD risk until further 
data are available , cautions should be excersised in prescribing HRT to 
females with a history of IHD or cardiopretective alone. (5) 
         It appears clear that estrogen deprivation increase the risk of 
cardiovascular disease in females. Data from the Framingham study have 
been used to compare the incidence of cardiovascular disease in males 
and females. Although the incidence is three times lower in females than 
in males before the menopause, it is approximately equal in males and 
females aged 75 to 79 being 53 and 50.4 / 1000 per year, respectively. 
This trend also pertains to gender difference in mortality due to 
cardiovascular disease. Coronary artery disease is the leading cause of 
death in females and the lifetime risk of death is 31% in postmenopausal 
females versus 3% risk of breast cancer. 
          Although cardiovascular disease became more prevalent only in 
later years following natural menopause, premature cessation of ovarian 
function (before menopause) constitutes a significant risk.  Premature 
menopause, occurring before age of 35, has been shown to increase the 
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risk of myocardial infarction two to threefold and premature 
oopherectomy (before age of 35) increase the risk sevenfold. (6)  
          Myocardial infarction has been recognized for long time as the 
leading cause of death among middle aged males but only recently it has 
been recognized as an equally important cause of death and disability 
among older females. By age of 60 years, only 1 in 17 females in the 
United States had a coronary event, compared with 1 in 5 males. 
However after age of 60, coronary diseases become the leading cause of 
death among females. In this age group 1 in 4 males will die as result of 
myocardial infarction. (7) 
           In a study done in Hvidore, Denmark in 1996, they found that 
females with acute myocardial infarction tend to be older than males. 
They are on average 4 years older than males with acute myocardial 
infarction. Some investigation suggested that the protecting role of 
premenopausal estrogen against ischemic heart disease explain the later 
manifestation of myocardial infarction in females, whereas others regard 
differences in life style, including smoking habits, to play an important 
role. (8) 
            Heart attack mortality is higher for females than males before age 
of 60, but opposite is true for females and males older than age of 79. 
Age was a significant predictor of death even after adjustment for 
numerous dimorphic and clinical characteristic of pattern and the 
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treatment they received. Non-biological factors may play a role, including 
behavioral, psychological, social factors such as smoking, adherence to 
medication regimens, depression, social isolation low income and 
emotional stress. 
             It has been reported in the literature that the isolated value of 
LDL–cholesterol plays a less significant role as a cardiovascular risk 
factor in females as compared with that in males. On the other hand, low 
LDL-cholestrol level has been considered as an important predictor of 
mortality among females. Currently a meta-analysis carried out at the 
National Heart, Lung and Blood Institute has shown that total 
hypercholesterolemia and high LDL-cholestrol levels correlated with a 
higher cardiovascular mortality in  females younger than 63 years old, but 
not in the elderly. (9) 
             In a study done in 20th of July 1996, in Denmark,  among 700 
women and 2300 men, it showed that females experiencing acute 
myocardial infarction tend to be older than males and that early mortality, 
10 years mortality, re-infarction rate, mortality after re-infarction or cause 
of death do not differ between sexes. In conclusion, this study indicates 
that sex itself is not an indicator of the risk after acute myocardial 
infarction. (8) 
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 B / Diabetes Mellitus:- 
Diabetes is a risk factor in the development of myocardial 
infarction, atherosclerosis, stroke and amputation. The risk is related to 
that of the background population. For examples, Japanese diabetics are 
much less likely to develop atherosclerosis than patients in Europe, but 
are much more likely to develop it than non-diabetic Japanese.   
Myocardial infarction is 3-5 times as likely and females with 
diabetes lose their pre-menopausal protection from coronary artery 
disease. (4) 
Estrogen enhance insulin sensitivity in females but not in men. Despite 
this, prevalence of type 2 diabetes mellitus (DM) is higher in females 
who are related in part to the higher prevalence of female obesity. Pre-
menopausal females with DM lose the cardioprotective effect of their 
female gender and have identical rates of IHD to those in males. This is 
partially explained by the presence of several IHD risk factors in females 
with DM = obesity, hypertension and dyslipidemia – recent evidence 
suggests that vascular responses differ in females with DM, as compared 
to normal females. (6) 
    DM and hypertension are less common in young patients. 
However, young patients commonly have subtle problems with glucose 
metabolism. 
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   In one study of 108 patients without history of diabetes mellitus 
who had an M.I. before the age of 45. 65 percent had decreased oral 
glucose tolerance and a hyper-insulinemic response to oral glucose 
challenge. (10) 
   Cardiovascular complications e.g. (myocardial infarction) are the 
leading cause of morbidity and mortality related to DM. complications of 
atherosclerosis are responsible for about 80% of death in diabetic patients 
and 75% of hospitalizations.  In a 7 years study conducted in Finland (11), 
the absolute risk for major cardiac events in patients who had type 2 
diabetes without coronary artery disease (CAD) was 20.2% compared 
with 18.8% in matched non-diabetic patients who had established CAD, 
even before the development of hyperglycemia / persons with impaired 
glucose tolerance have an elevated risk of macro-vascular disease. Fifty 
percent of patients have evidence of cardiovascular disease at the time of 
diagnosis of type 2 diabetes. (12)  
    A study published in the Brazil (2002) indicates that DM was 
least prevalence risk factors (in young males and females with acute 
myocardial infarction) Present in 10% of the patients of both sexes. One 
is possible justification for the lower prevalence of diabetes mellitus in 
young patients of both sexes after acute myocardial infarctions could be 
the fact that the atherogenic effects of DM on the cardiovascular system 
appears through the years. (13)  
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    Good evidence suggests that hyperlipidemic, diabetes and 
hyperhomocystinemia are risk factors for CHD in females. Risk factors 
for CHD seen to be equally strong in males and females with the possible 
exception of the age, diabetes, and certain lipoproteins. 
 
C / Hypertension: 
   Patients with hypertension die prematurely; the most common 
cause of death is heart disease, coma with stroke and renal failure. Angina 
pectoris may also occur because of the combination of accelerated 
coronary arterial disease and increase myocardial oxygen requirement as 
a consequence of the increased myocardial mass. 
   Evidence of Ischemia or infarction may be observed late in the 
disease. 
   Most heart deaths due to hypertension results from myocardial 
infarction or congestive heart failure. Recent data suggest that some of 
the myocardial damage may be mediated by aldosteron in the presence of 
a normal / high salt intake rather than just the increased blood pressure or 
an increase in angiotension II level per se. (6) 
   Effective treatment of hypertension significantly reduces 
cardiovascular mortality and morbidity. The relative risk of stroke is 
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reduced by up to 40% and M.I by 20%. Although the incidence of M.I 
exceeds that of stroke the absolute risk reductions are similar. (14) 
   Hypertension is more common in U.S. females than males, 
largely owing to the high prevalence of hypertension in older age groups 
and longer survival rate for women. Both the effectiveness and adverse 
effects of various antihypertensive drugs appear to be comparable in 
females and males. Benefits of treatment for severe hypertension have 
been dramatic in both females and males. However, in clinical trials of 
the treatment of mild to moderate hypertension, females has had smaller 
decrease in morbidity and mortality than males, perhaps because females 
have a low risk of M.I and stroke than males, but it was found that older 
females benefit at least as much as males from treatment, which was 
demonstrated by the systolic hypertension in elderly study. The incidence 
of hypertension (above 140/90) appears to be low (less than 5%) with the 
current low-dose & oral contraceptives. Postmenopausal estrogen therapy 
is not associated with increase in the blood pressure. (6)  
In another study, done by CoronadoBe, Griffith II (1997) of nearly 
11000 older patients (half of which were females) who arrived with 
cardiac symptoms. It was found that females had more hypertension (55 
percent vs. 46 percent) and diabetes (23 percent vs. 17 percent) compare 
to men but, had suffered fewer previous heart attacks (21 percent V-S -29 
percent). They also had more heart damage than males. (15)  
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  In the elderly program of systolic hypertension, in which females 
made up to 57% of the study population, antihypertensive treatment 
resulted in a 36% reduction in the incidence of stroke and 25% reduction 
in that of CAD. (7) 
 
Cigarette Smoking & Health: 
   Cigarette smoking acts synergistically with other cardiac risk 
factors to increase the risk of Ischemic heart disease. Although the risk of 
cardiovascular diseases is roughly proportional to cigarette consumption, 
the risk persist even at low levels of smoking, that is, one to two cigarette 
per day. Cigarette smoking reduces exercise tolerance in patients with 
angina pectoris and intermittent claudication. Vasospastic angina is more 
common and the response to vasodilator medication is impaired in 
patients who smoke. The number of ischemic episodes and total durations 
as assessed by ambulatory electrocardiographic monitoring in patients 
with coronary heart disease are substantially increased by cigarette 
smoking. The increase in the relative risk of coronary heart disease 
because of cigarette smoking is greatest in young adults, who in the 
absence of cigarette smoking would have a relatively low risk. Females 
who use oral contraceptives and smoke have a synergistically increased 
risk of both myocardial infarction and stroke. 
 21
   After acute M.I, the risk of recurrent myocardial infarction is 
higher and survival is half over the next 12 years in persistent smokers as 
compared with quitters. Smoking interferes with revascularization 
therapy for acute M.I. after thrombolysis, and the reocclusion rate is four-
fold higher in smokers who continue than in those who quit. The risk of 
reocclusion of coronary artery (after angioplasty or a bypass graft) is 
increased in smokers. Cigarette smoking is not a risk factor for 
hypertension per se but does increase the risk of complications, including 
the development of nephrosclerosis and progression to the malignant 
hypertension. (16) 
    Studies of smoking and cardiovascular disease may have 
underestimated the risk in females because until recently females 
smoking habits have differed greatly from males. However, during the 
past few decades, females have taken up smoking like males. Using data 
from three large prospective studies in Copenhagen that included many 
females who were heavy smokers, (Prescott et al) found that the smoking 
related risk of myocardial infarction was 50% higher in females than in 
males. This difference may be caused by interactions between  
  In a study published in England, Scotland and Wales (1999), 
about risk of M.I in young female smokers, there was no interaction of 
smoking with the use of oral contraceptives, but there were additive risks 
with other clinical risk factors such as hypertension and diabetes. It is 
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estimated that if all females aged  16-44 years were able to stop smoking 
1400 cases of M.I per annum (of whom 112 would died) would be 
prevented. In conclusions, in young females the risk of M.I from smoking 
was considerable and heavy smokers with other risk factors were 
especially at risk.  (17) 
     In a study done by Stone, Shapiro (18) to examine the relation 
between M.I and cigarette smoking in young females, they investigated 
the smoking habits of females under age of 50 who had survived a recent 
M.I. they had not bear using oral contraceptives, and other identifiable 
risk factors were  excluded. Among 55 such females and 220 controls 
matched for age and area of residence, the proportions of cigarette 
smokers were 89 percent and 55 percent respectively (P less than 0.001).     
  A Dose response relation was evident, among females smoking 
35 or more cigarette per day the rate of M.I was estimated to be some 20-
fold higher than among those who had never smoked. This study 
demonstrated that cigarette smoking is a risk factor for M.I in young 
females who are otherwise apparently healthy. 
  Other study established in Denmark, Copenhagen City heart 
study(19) to compare risk of M.I associated with smoking in males and 
females taking into consideration differences in smoking behavior and a 
number of potential confounding variables, they found that females may 
be more sensitive than men to some of the harmful effects of smoking. 
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Interactions between components of smoke and hormonal factors that 
may be involved in the development of Ischemic heart disease should be 
examined further, which was found as a possible cause of the sex 
differences. 
           There is a growing epidemiological evidence that females who 
smoke are relatively deficient in estrogen, they have an earlier 
menopause, decreased risk of cancer of the endometrium, greater 
likehood of osteoporosis (osteoporotic fractures), and reduced incidence 
of a number of minor” disorders such as uterine fibroids. 
   Recently found that the relative mortality from vascular diseases 
was higher in a female smoker than in a male smoker. (20) 
             In a study done by Eva Prescott, Merete Hippe (April 1998), they 
found that sex difference in the effect of tobacco can not simply be put 
down to differing base line rates. Although relative risk are higher in 
females, suggesting differences in mechanism of action of tobacco in 
males compare to females, smoking may well cause more cases of M.I 
among males in this study population. The difference in risk was higher 
in males to age of 65 and in females after age of 65. (21) 
Other Factors: 
          A variety of other possible contributing factors have been identified 
in young patients with M.I these include: 
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Oral contraceptive: use in young females, particularly in combination 
with smoking. (22) 
Defective fibrinolytic function: mainly due to elevated plasma 
plasminogen activator inhibitor -1 ((PA/ -J)) activity. (23) 
 
The role of psychosocial and other social factors in M.I: 
Life events and other crisis:  one report in 1975 found that stressful 
life events occurred among 40 of 100 sudden dearth victims in 24 hours 
preceding death. (24) Since this and related studies are subjects to the 
criticism of biased recall by relatives or friends of the victims. 
prospective studies are somewhat more reliable. 
  In a large cohort of middle- aged widowers, for example, a 40 
percent increase in the mortality rate in the first 6 months was observed 
following bereavement, more than half of which was attributed to 
cardiovascular causes. (25) It is unclear how much of this increase in 
mortality was due to lifestyle changes during grieving period rather than 
to stress per se. 
Personality and mood:  studies of the role of personality in the 
etiology of coronary artery disease had yielded controversial results. 
However, there is increasing evidence that hostility, cynicism and anger 
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from a critical “toxic” component of type A behavior is associated with 
enhanced cardiovascular risk. (26) 
Depression:  
 Although there is mounting evidence that depressive symptoms 
are associated with increased cardiovascular risk, it remains uncertain 
whether the symptoms are playing a causative role or whether they are 
primarily a marker or a prodrome of an evolving event. As early as 1937, 
the mortality among 1900 patients hospitalized for depression was found 
to be six fold than that of an age- Matched population. More recent 
studies have confirmed this association. (27) 
 
 Seasonal Pattern: 
Several series have demonstrated a seasonal pattern of death from 
M.I, with more fatal events (20 to 30 percent variation) occurring in the 
winter than summer. As an example, a recent report from the National 
Registry of myocardial infarction evaluated 259, 891 cases from 1474 
hospitals during a 25 months period, approximately 53% , more 
infarctions occurred in the winter or spring compared to the summer. The 
trend were independent of gender, geographic location, age, and the type 
((Q wave or non- Q wave)) of M.I. In hospital, fatality rates from M.I 
 26
also followed a seasonal pattern, with a peak of 9 percent in winter and a 
nadir in the spring. 
However, a seasonal pattern is absent in diabetics or those taking beta 
blockers or aspirin, suggesting an important role for the sympathetic 
nerves system. (28) 
 
Risk stratification for cardiac events after acute myocardial 
infarction: 
       The process of risk stratification in patients who has had an acute M.I 
has two components: 
• Identification of patients at increased risk for recurrent 
Ischemic events. 
• Identification of patients at increased risk for arrhythmic or 
non-arrhythmic death. Arrhythmias, for example, are the 
most frequent cause of death during the first year after an 
M.I. 
Early risk stratification:  risk stratification of the post- M.I patient 
begins as soon as the patient arrives to the coronary care unit (CCU). 
There are many clinical prognosis factors that are immediately available 
to the physician based upon the initial history, physical examination, 
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electrocardiogram (ECG) and chest x-ray. Most of these prognostic 
factors have been recognized for over 30 years. 
? Heart rate: Although heart rate may be elevated soon after the 
patient arrives in the C.C.U, it usually declines thereafter to a level 
which reflects the degree of activation of sympathetic nervous 
system. 
Patients with sustained heart rates >90 beats/min usually have marked 
impairment of left ventricular (LV) function and therefore, a poor 
prognosis. (29) 
? Heart failure: evidence of heart failure (HF) on physical 
examination or chest x-ray indicates extensive LV systolic and /or 
diastolic dysfunction and is associated with worse prognosis 
compared to those with no pulmonary congestion. Right ventricular 
HF or biventricular HF is associated with an elevation in jugular 
venous pressure. 
Killip class: the killip classification, published in 1967, categorizes 
patients with an acute M.I based upon the presence or absence of 
simple physical examination findings that suggest LV dysfunction(30): 
 Class I – no evidence of HF 
Class II – findings consistent with mild to moderate HF (S3, lung            
rates less than one-half way up the posterior lung fields, or jugular 
venous distension) 
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Class III - overt pulmonary edema 
Class IV - cardiogenic shock. 
The higher the killip class, the greater the in-hospital mortality. The killip 
class remains prognostically important, even in patients who undergo 
thrombolytic or primary percutaneous coronary intervention (Angioplasty 
with or without stenting).                                                                                     
-   Hypotension :  
Hypotension (systolic pressure < 100 mm Hg) or frank shock was 
associated with a poor prognosis. This is especially true in the patient 
with an anterior M.I in whom hypotension is the result of extensive 
myocardial damage and markedly reduced LV ejection fraction 
(LVEF). In comparison, hypotension in the presence of an inferior M.I 
may be the result of increased vagal activity, the so-called Bezold- 
darisch reflex. 
-  New Q waves on the ECG:  
In patients with an ST elevation acute M.I., the presence of pathologic 
Q waves on the ECG signifies an irreversible myocardial necrosis. 
However, the prognostic importance of new pathological Q waves on 
the presenting ECG is uncertain.  
  This was examined in one study of 481 patients presenting within 
four hours of symptoms onset. New Q waves were associated with lower 
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LVEF, an increased 30 days cardiac mortality, and an increased mortality 
after a five years follow –up (31). 
Arrhythmia:   
The presence of certain arrhythmias beyond the first 24 to 48 hours post- 
MI predict a worse prognosis. These include a trial fibrillation (AF), 
ventricular tachycardia (VT), and ventricular fibrillation (VF). 
 AF is the most common supra ventricular arrhythmias after an M.I. The 
GISSI- Z trial, for example, evaluated over 11,000 patients treated with 
thrombolytic therapy for acute M.I. (32) 
TIMI risk score:  
The TIMI risk score, based upon data from 15,000 patients with an ST 
segment elevation M.I eligible for fibrinolytic therapy, is a simple 
arithmetic sum of eight independent predictors of mortality. (33) 
Stress hyperglycemia:   
There is a positive association between hyperglycemia at the time of an 
MI and mortality. The evidence that the use of insulin to lower glucose 
concentration reduces mortality in patients with diabetes suggests that 
hyperglycemia is not only an epiphenomenon of stress response mediated 
by sympathetic stimulation. (34) 
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Prognosis after acute myocardial infarction: 
            It is well established that females with M.I have a worse prognosis 
than men, but disagreement persists about whether this reflects 
differences in age, risk profiles, or treatment given to females with M.I 
are typically older than men, and some investigators have found the 
differences in age, sufficient to account for all their excess risk. Also, 
hypertension and diabetes may be more common in females, and this 
factor too may contribute to the prognostic imbalance between the sexes. 
More recently, evidence has shown that females with coronary heart 
disease tend to be treated less intensively than males. If this applies to use 
of thrombolysis and drugs such as aspirin and B blockers, it may not only 
help explain females less favorable out come but also provide a relatively 
simple remedy for correcting it. 
    Although females with M.I have a worse prognosis than males, it 
is not known for how long after the acute phase the excess risk persists. 
Certainly, the survival curves for females and males presented by 
previous investigators are in most cases approximately parallel after 
initially diverging, which implied that the excess risk in females is a 
temporary phenomenon that eventually disappears. It is important, 
however, that the time it takes to disappear is defined and it's specific 
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strategies are to be developed to protect females with acute M.I during 
the period of heightened risk. 
 
Sex related difference in short and long term prognosis after 
acute M.I: 
In a study done by Galatius – Jensen, Registrare, JLaunbjerg, 
senior registrare (35), they found that: sex by itself is not a risk factor after 
acute M.I. females and males have similar mortality at 10 years follow 
up. Causes of death are not different between both sexes. Females and 
males have similar re-infarction rates and similar subsequence mortality. 
The prevailing view regarding sex as an independent prognostic factor 
after acute M.I may be due to present difference in treatment of females 
and males, selection bias, and the interpretation of the role of age 
differences. 
 In other study done by Ayaniant JZ (2001) (36), they found that 
heart attack mortality is higher in females than males before the age of 
60, but the opposite is true for females and males older than age 79. Age 
was a significant predictor of death even after adjustment for numerous 
demographic, clinical characteristics of patients and the treatments they 
received. Non biological factors may play a role, including behavioral, 
psychological, and social factors such as smoking, adherence to 
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medication regimens, depression, social isolation, low income, and 
emotional stress.  
   Females are 20 percent more likely than males to die in the 
hospital following a heart attack. (37) This study of overt 12,000 females 
and males treated for heart attack in Seattle area hospitals between 1988 
and 1994 found that even after accounting for differences between males 
and females in cardiac procedures, age and health factors, females were 
still 20 percent more likely to die than males. They also were less likely 
than males to receive clot-busting (thrombolytic) therapy promptly or 
bypass surgery. 
   Females received less aggressive treatment than males after a 
heart attack and are more likely to die while in hospital. (38) This study 
found that females continue to lag behind males in both treatment 
received and outcomes. Differences in age and severity of illness did not 
explain the variations seen in this study, which involved more than 
14,000 patients admitted for heart attacks to 100 U.S hospitals in 1991. 
Lack of studies on females limits usefulness of research on coronary heart 
disease: 
 Press release date: July 10/2003. 
Although coronary heart disease (CHD) is the cause of more than 
250,000 deaths in females each year, much of the research in the last 20 
years on the diagnosis and treatment of CHD has either excluded females 
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entirely or included only limited numbers of females and minorities. As a 
result, many of tests and therapies that are used to treat females for CHD 
are based on studies conducted predominantly in males.  
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Objectives 
 
• To identify the main clinical presentation of myocardial infarction 
among the Sudanese female. 
 
• To determine the risk factor of acute myocardial infarction among the 
Sudanese females including family history, diabetes mellitus, 
hypertension and smoking.  
 
 
 
 
 
 
 
 
 
                           Methodology 
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Study area:  Al Shaab Teaching Hospital. 
Study period: October 2003- June 2004. 
Population:  
All females' patients admitted to coronary care unit (CCU) with acute 
myocardial infarction during this period. 
All female patients admitted to CCU were interviewed, examined and 
investigated.  
Data collected using questionnaire.  
The questionnaire included personal data and the risk factors of MI 
(diabetes mellitus, hypertension, hyperlipidemia, smoking and positive 
family history).  
ECG was done for each patient. 
Blood sample was taken for blood film of malaria, blood glucose, cardiac 
enzymes and lipid profile. 
 
 
 
Inclusion criteria: 
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All females presented with acute transmural myocardial infarction, as 
evidenced by ECG changes (Q formation and ST segment elevation). 
Exclusion criteria: 
Females with other cardiac diseases (congenital and valvular heart 
disease and myopathies) and ECG changes of Bundle Branch Block were 
excluded. 
Sampling: 
Randomized 100 cases of female patients with acute MI were selected. 
Data collection and analysis: 
The data was collected by a self administered simple questionnaire and 
then analyzed and represented in a statistical manner.   
 
 
 
 
 
 
 
 
RESULTS 
 This study was conducted on 100 female patients with myocardial 
infarction. 21% of the patient between 40-50 years, 35% between 51-60 
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years, 33% between 61-70 years and 11% more than 70% years      
(Figure 1).   
 Most of the patients 59% originally from Northern Sudan, 26% 
from Central, 21% from Western, 2% from Southern and 1% from 
Khartoum (Figure 2).  
 89% of the patient were housewife, while 5% employed, 55% 
labourer and 1% others (Figure3). 
 The patient were married is 49%, widow 39%, divorced 8% and 
4% were single (Figure 4). 
 The patient were illiterate 62%, 22%  had a primary school 
education level,  13%, intermediate school and only 3% completed the 
university studies (Figure5). 
 The distribution of the patients according to their number of 
pregnancies were 20% 1-3, 43% 4-6 and 37% > 6 (Figure6). 
 Distribution of presenting symptoms, 92% presented with chest 
pain, 32% presented with shortness of breath and 24% presented with 
palpitation (Figure 7, 8, 9). 
 The patients that had a family history of  ischemic heart disease is 
only 28% (Figure 10). 
 The risk factors of smoking are shown in (Figure 11, 12), 9% of 
the patients used to smoke and duration more than 10 years in 55% of 
patients. 
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  (Table 3) showed that who used to smoke were 11% in the age 
group 40-50, 44% in 51-60 years and 12% more than 70% years. 
 The distribution of systemic hypertension as a risk factor is shown 
in (Figure 13-14), 40% had systemic hypertension and duration more 
than 15 years in 23%. 
(Table 4) showed that those were known to be hypertensive were 
19% in age group 40-50 years, 35% in 61-70 years and 11% more than 70 
years. 
 Diabetes mellitus occurred in 46% with a duration of more than 15 
years in 35% (figure 15 and table 1),  10% of them are in age group 
more than 70% years (table 2). 
 Distribution of presenting signs, 34% presented with high blood 
pressure, 4% had a sign  of hyperlipdaemia and 16% of the patient were 
pale on admission (Figure 16-17). 
 (Table 6) showed that 12% of the patients in the age group      
40—50 presented with pallor, 19% in 51-60 years, 50% in 60-70 years 
and 19% more than 70 years. 
 Only 3% of the patient presented with arrthymias   and 6% 
presented with sign of heart failure (table 7 and 8).   
 Random blood sugar was high in 44% (figure 19). Normal Hb% in 
80% and  20% had low Hb% (figure 20). BFFM  positive in 12% of the 
patients while 88% had negative result  (Figure 21%). 
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 ECG showed 55% of the patients had anterior MI, 38% had 
inferior M.I, while 7% had posterior M.I (table 9). 
 Cardiac enzyme are high in 42%, while 58% had abnormal result  
(table 10).  
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Figure (1):- Distribution of the 100 Sudanese female 
                    with MI according to their age. 
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Figure (2):-Distribution of the 100 Sudanese female with MI 
                                 according to their tribe. 
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Fig ( 3 ) :-   Distribution of a 100 Sudanese female with MI 
according to their occupation 
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Fig ( 4 ) :-   Distribution of a 100 Sudanese female with MI 
according to the marital status   
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Fig ( 5 ) :-   Distribution of a 100 Sudanese female with MI 
according to their education level 
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Fig ( 6 ) :-   Distribution of a 100 Sudanese female with MI 
according to their number of pregnancy  
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Fig ( 7 ) :-   Distribution of a 100 Sudanese female with MI 
according to their chest pain 
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Fig ( 8 ) :-   Distribution of a 100 Sudanese female with MI 
according to their shortness of breath 
          Yes  
        No 
32% 
68%
0 
20 
40 
60 
80 
100 
 48
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig ( 9 ) :-   Distribution of a 100 Sudanese female with MI 
according to their palpitation  
          No  
        Yes 
24% 
76%
0 
20 
40 
60 
80 
100 
 49
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Fig ( 10 ) :-   Distribution of a 100 Sudanese female with MI 
according to their family history 
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Fig ( 11 ) :-   Distribution of a 100 Sudanese female with MI 
according to their cigarette smoking 
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 Figure (12):- Distribution of a 100 Sudanese female with MI  
   According to the duration of smoking 
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Fig ( 13 ) :-   Distribution of a 100 Sudanese female with MI 
according to their systemic hypertension  
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Fig ( 14 ) :-   Distribution of a 100 Sudanese female with MI  
according to the duration of hypertension  
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Fig ( 15 ) :-   Distribution of a 100 Sudanese female with MI 
according to their Diabetes Mellitus  
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Fig ( 16 ) :-   Distribution of a 100 Sudanese female with MI 
according to their pallor 
16% 
84%
0 
20 
40 
60 
80 
100 
          No  
        Yes 
 56
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig ( 17 ) :-   Distribution of a 100 Sudanese female with MI 
according to their signs of hyperlipidaemia 
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Fig ( 18 ) :-   Distribution of a 100 Sudanese female with MI 
according to their lipid profile  
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Fig ( 19 ) :-   Distribution of a 100 Sudanese female with MI 
according to their RBG  
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Fig ( 20 ) :-   Distribution of a 100 Sudanese female with MI 
according to their HB  
          Normal  
        Low 
80% 
20%
0 
20 
40 
60 
80 
100 
 60
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Fig ( 21 ) :-   Distribution of a 100 Sudanese female with MI 
according to their BFFM+ICT for Malaria 
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    Table (1) 
 
   Distribution of the 100 Sudanese female with MI 
            according to their duration of Diabetes. 
 
 
 
Diabetes duration                  Percent 
                   1-5years                          15 
                  6-10years                          20 
                 11-15years                          30 
                  >15years                          35 
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                                            Table (2) 
                                                
   The relation between the age and the presence  
              of Diabetes in the studied group. 
 
 
 
Distribution of age               Diabetes Mellitus 
                             40-50                               24% 
                             51-60                               33% 
                             61-70                               33% 
                             >70                               10% 
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    Table (3) 
 
    The relation between the age and the smoking  
                         in the studied group. 
 
 
 
 
 
 
 
 
 
DISTRIBUTION OF AGE CIGARETTE SMOKING 
40-50 11 
51-60 44 
61-70 33 
>70 12 
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                                                 Table (4) 
 
      The relation between the age and the hypertension  
                               in the studied group. 
 
 
 
 
 
 
 
 
DISTRIBUTION OF AGE SYSTEMIC HYPERTENSION 
40-50 19 
51-60 35 
61-70 35 
>70 11 
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          Table (5) 
 
    Distribution of the study population according  
                          to their BP level. 
 
 
 
 
 
 
 
 
 
 
BP PERCENT 
Hypertension 34 
Normal BP 60 
Hypotension 6 
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                                           Table (6) 
 
        Co-relation between pallor and the age of the  
                   100 Sudanese female with MI. 
 
 
 
 
 
 
 
 
 
Distribution of age                     Pallor 
                    40-50                               12% 
                    51-60                              19% 
                    61-70                               50% 
                    >70                               19% 
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                                  Table (7) 
 
    Distribution of a 100 Sudanese females with MI  
                     presented with Arrthymia. 
 
 
 
 
Arrthymia Percent 
Yes 3% 
No 97% 
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                                   Table (8) 
 
    Distribution of a 100 Sudanese females with MI  
               presented with signs of heart failure. 
 
 
 
 
Signs of heart failure Percent 
Yes 6% 
No 94% 
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Table (9) 
 
  The types of MI. 
 
 
 
 
 
 
 
 
 
FEATURE Of ACUTE TRANSMURAL PERCENT 
ANTERIOR 55 
POSTERIOR 7 
INFERIOR 38 
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Table (10) 
 
                     The level of cardiac enzymes. 
 
 
Cardiac enzymes                Percent 
               Normal                           42 
             Abnormal                          58 
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                       DISCUSSION         
 
 
Coronary heart disease (CHD) is a common disease and cause of 
death in women, accounting for over 250.000 deaths in women per year. 
Over the last two decades, multiple important studies have helped define 
accurate clinical tests, risk factors, preventive interventions and effective 
therapies for CHD. 
          Unfortunately, many of these studies have either excluded women 
entirely or included only limited numbers of women and minorities. 
Thus, much of the evidence supporting contemporary recommendations 
for testing, prevention, and treatment of coronary disease in women is 
extrapolated from studies conducted predominantly in middle-aged men. 
The two best approaches to obtain additional evidence on diagnosis and 
treatment of CHD in women are to conduct large studies that include 
adequate numbers of women and minorities to answer the research 
question or to perform systematic reviews and meta-analyses 
summarizing effect estimates by sub group.                        
           According to Figure 1, 21% of the cases in the study lie in the age 
group (40-50), 38% in the age group (51-60), 33% in the age group (61-
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70) and 11% in the age group more than 70 years. In conclusion, 
approximately two third of the patients (68%) lie in the age group ranging 
from (51-70), and this is consistent with the fact that estrogenic as 
cardioprotective so the incidence of M.I increases markedly at 
menopause. 
The majority of the patients were housewife (89%), while 5% employed 
and 5% labourers. (Figure 3)                           
               Less than half (49%) of the patients were married, while 39% 
were widows followed by 8% divorced and 4% single. This result showed 
that chronic psychological distress may be associated with acute coronary 
syndromes. (Figure 4) As in a study done on 1998 company130 patients 
with an acute MI or unstable angina to 102 control subjects hospitalized 
for acute trauma found that cardiac patients had higher levels of social 
isolation, self-blame, avoidance, and more painful life experiences 
compared with controls. High levels of psychologic distress were 
detectable on about 75% of cardiac patients. (39) 
         The majority of the patients (62%) were illiterate, where 22% had a 
primary school education level, 13% intermediate school and only 3% 
complete the university. (Figure 5) 
          The number of pregnancies in the patients were 20% (1-3), while 
43% (4-6) and 37% had more than 6. (Figure 6) 
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          Chest pain in the presenting complains in 92% of patients, followed 
by shortness of breath in 32%, while 24% presented with palpitation. 
(Figure 7, 8, 9)  
          The family history only accounts for 28% in patients. (Figure 10) 
          The percentage of the patients who used to smoke were 9%, but the 
real percentage may be higher since this is forbidden socially. (Figure 11) 
           According to the results in figure (12), the duration of smoking is 
not related to MI in those who used to smoke. 77% of those who used to 
smoke lie in the age group (51-70) years. (Table 3)  
            The percentage of the patients who had systemic hypertension 
(HTN) was 40%. (Figure 13)  
            35% of them had HTN for (1-5) years, followed by 30% (6-10) 
years while 12% (11-15) years and 23% for more than 15 years.      
(Figure 14) 
           The majority of the patients (70%) lie in the age group (51-70) 
years, which was the main age group of the patients. (Table 4)  
           46% of the patients had DM, of whom 15% had the disease for (1-
5) years, 0% (6-10) years, 30% (11-15) years and 35% for more than 15 
years. This shows that the duration of DM is a risk factor for M.I. (Table 
1 & Figure 15)        
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The percentage of the patients who had anemia on admission were 
16%, 69% of them lie in the age group (51-70) years. (Figure 16 &   
Table 6) 
           The majority of the patients who had a normal BP (60%), while 
(34%) had a high BP and only (6%) were hypotensive. (Table 5)  
            Only 4% of the patients had signs of hyperlipidaemia on 
presentation. (Figure 17) 
           According to the investigations done the majority of the patients 
(73%) had a normal lipid profile. (Figure 18) 
            Most of the available data on cholesterol and M.I were derived 
from studies of middle age men in whom it had been observed that for 
every 1% decrease in total serum cholesterol, there is (2-3)% reduction in 
risk of M.I similarly the risk of M.I increases by (2-3)% for every 1 mg / 
dl decrease in HDL cholesterol, also low HDL cholesterol levels in 
women may be more predictive for subsequent coronary events than high 
levels of HDL cholesterol. (40)  
           80% of the patients had a normal HB % and only 12% had a 
positive BFFM. (Figure 20, 21) 
           At time of presentation 51% of the patients had a normal blood 
glucose level, 44% had high blood glucose and 5% had impaired test. 
(Figure 19) 
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         There is a positive association between hyperglycemia at the time of 
an M.I and mortality. The evidence that the use of insulin to lower blood 
glucose concentration reduces the mortality in patients with diabetes 
suggests that hyperglycemia is not only an epiphenomenon of the stress 
response mediated by sympathetic stimulation. (41) 
      3%of the patients presented with arrthymia and 6% with signs 
of heart failure. (Table 7 & 8) 
               55% of the patients had an anterior M.I while 38% had an 
inferior M.I and only 7% had posterior M.I. (Table 9) 
               58% of the patients had abnormal results of cardiac enzymes at 
time of presentation (CK-MB). (Table 10) 
               The prognostic significance of the small elevation of (CK-MB), 
which represents an evidence of myocardial damage, in patients with 
unstable Angina is uncertain. The relationship between peak (CK-MB) 
level and outcome in patients with an acute coronary syndrome 
unassociated with ST segment elevation was evaluated in the PURSUIT 
trial of 8250 patients from whom at least one (CK- MB) reading was 
obtained. The mortality was related to the presence of an elevated (CK-
MB) level and the degree of evaluation. (41)  
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CONCLUSION 
 
In conclusion, it was found that large number of the patients present after 
the age of 50 years. 
The majority of patients were multipara (more than 6 pregnancies). 
The commonest presenting complain was chest pain. 
To be more precise the diabetes mellitus was the main risk factor. 
Quite small number of patients were found to be anaemic (only 16 %). 
More than half of the patients had elevated cardiac enzymes (CK-MB). 
The majority of the patients present with Anterior MI, then Inferior MI 
and Posterior MI. 
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                                     Recommendations   
   
 
• All female patients should undergo aggressive control for their 
diabetes and hypertension. 
• All patients should undergo aggressive reduction for dyslipidemia 
and even patients with high-normal serum cholesterol 
concentrations have been shown to benefit from lipid lowering. 
• All female should encourage stopping smoking. 
• Early assessment and management of the high risk patients. 
• Further long term prospective studies on larger number of patients 
are warranted to evaluate the risk factors and to assess its role in 
predicting future MI in females. 
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RESULTS 
 This study was conducted on 100 female patients with myocardial 
infarction. 21% of the patient between 40-50 years, 35% between 51-60 
years, 33% between 61-70 years and 11% more than 70% years      
(Figure 1).   
 Most of the patients 59% originally from Northern Sudan, 26% 
from Central, 21% from Western, 2% from Southern and 1% from 
Khartoum (Figure 2).  
 89% of the patient were housewife, while 5% employed, 55% 
labourer and 1% others (Figure3). 
 The patient were married is 49%, widow 39%, divorced 8% and 
4% were single (Figure 4). 
 The patient were illiterate 62%, 22%  had a primary school 
education level,  13%, intermediate school and only 3% completed the 
university studies (Figure5). 
 The distribution of the patients according to their number of 
pregnancies were 20% 1-3, 43% 4-6 and 37% > 6 (Figure6). 
 Distribution of presenting symptoms, 92% presented with chest 
pain, 32% presented with shortness of breath and 24% presented with 
palpitation (Figure 7, 8, 9). 
 The patients that had a family history of  ischemic heart disease is 
only 28% (Figure 10). 
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 The risk factors of smoking are shown in (Figure 11, 12), 9% of 
the patients used to smoke and duration more than 10 years in 55% of 
patients. 
  (Table 3) showed that who used to smoke were 11% in the age 
group 40-50, 44% in 51-60 years and 12% more than 70% years. 
 The distribution of systemic hypertension as a risk factor is shown 
in (Figure 13-14), 40% had systemic hypertension and duration more 
than 15 years in 23%. 
(Table 4) showed that those were known to be hypertensive were 
19% in age group 40-50 years, 35% in 61-70 years and 11% more than 70 
years. 
 Diabetes mellitus occurred in 46% with a duration of more than 15 
years in 35% (figure 15 and table 1),  10% of them are in age group 
more than 70% years (table 2). 
 Distribution of presenting signs, 34% presented with high blood 
pressure, 4% had a sign  of hyperlipdaemia and 16% of the patient were 
pale on admission (Figure 16-17). 
 (Table 6) showed that 12% of the patients in the age group      
40—50 presented with pallor, 19% in 51-60 years, 50% in 60-70 years 
and 19% more than 70 years. 
 Only 3% of the patient presented with arrthymias   and 6% 
presented with sign of heart failure (table 7 and 8).   
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 Random blood sugar was high in 44% (figure 19). Normal Hb% in 
80% and  20% had low Hb% (figure 20). BFFM  positive in 12% of the 
patients while 88% had negative result  (Figure 21%). 
 ECG showed 55% of the patients had anterior MI, 38% had 
inferior M.I, while 7% had posterior M.I (table 9). 
 Cardiac enzyme are high in 42%, while 58% had abnormal result  
(table 10).  
        
 
 
  
  
  
 
  
  
  
 
 
 
 
